cGxP.wire https://validator.w3.org/feed/docs/rss2.html DelveInsight Highlights Myotonic Dystrophy Market Growth Through 2036 Theranica Reports 91% Precision in AI Migraine Forecasting Study Avabello Aesthetics Founder Joins 2026 IAFA Aesthetic Symposium Lupus Research Alliance Awards $450K to Advance Lupus Therapies Oracle Expands Life Sciences Data Intelligence With AI and RWD ViferaXS Raises €12M to Advance CLL Phase II Trial Johnson & Johnson Reports TREMFYA Axial PsA Study Data Pharming Gains FDA Priority Review for Lower-Dose Joenja ITM Reports Re-treatment and Dosimetry Data for 177Lu-Edotreotide Tempo Therapeutics Wins $2.25M NIH Grant for Wound Healing HUTCHMED Initiates Global Phase I Trial of HMPL-A830 Flen Health and AGC Biologics Advance Enzyme Wound Therapy Alume Biosciences Gains FDA Breakthrough Therapy Designation for Bevonescein Johnson & Johnson Unveils Next-Gen Trauma Innovations at OTA 2026 BMS Reports EXCALIBER-RRMM Results for ZENBEXUS AustinPx Gains FDA AMT Designation for KinetiSol Technology Zymeworks Completes $929M Theravance Biopharma Acquisition Adaptive Highlights MRD Testing in New Myeloma Cure Definition Newron Expands ENIGMA-TRS 2 Enrollment Outside U.S. Nanoscope Advances Optogenetic Therapy for Retinal Diseases SELLAS Presents SLS009 Preclinical Data in Pancreatic Cancer Apertura and Lexeo Advance Gene Therapy for Friedreich Ataxia Astellas Starts Phase 3 Study of Setidegrasib in Lung Cancer GRAIL Galleri Wins FDA Panel Support for Cancer Test Variant Bio Expands Boehringer Cardiovascular Discovery Deal Elevar Therapeutics Wins FDA Approval for Lyrfigtu InnoCare and Lilly Sign $3.35B Drug Discovery Deal Myrava Wins FDA Clearance for 3D-Printed Radiation Bolus RIVANNA Reaches 100 Patents for AI Ultrasound Platform Gravity Diagnostics Expands Laboratory Testing Care Pathways Smith+Nephew Advances Knee Replacement With LANDMARK System C4 Therapeutics Presents Cemsidomide Biomarker Data in Multiple Myeloma Fate Therapeutics Receives $15 Million CIRM Grant for FT819 Ocugen Gains Provisional Approval for OCU400 in The Bahamas Aptar Pharma and Macquarie University Advance Inhaled Biologics Research Merck Gains FDA Label Update for WINREVAIR in PAH AstraZeneca Gains US Priority Review for IMFINZI in MIBC Persevere Therapeutics Doses First Patient in MIROC-1 Evommune to Present EVO301 Phase 2a Data at EADV 2026 Merck Reports Positive Phase 2b/3 BRUNELLO Results for Remigromig Boehringer Ingelheim Expands Rabies Prevention in Zimbabwe Acadia Reports Phase 2 RADIANT Results for Remlifanserin AstraZeneca Trixeo Wins EU Approval for Asthma Treatment Verastem to Present RAMP 201 Biomarker Data at IGCS 2026 Flagship Wins $47M Deal for Next-Gen Medical Countermeasures Revvity Launches CE-IVDR T1D Early Detection Solution Altasciences Supports 4B Healthcare’s RhineX Clinical Advance Cardiol Expands Phase III MAVERIC Trial in Pericarditis Care Innovent Advances Oncology Pipeline With New ESMO 2026 Data! Decoy Therapeutics Corrects Warrant Inducement Announcement